§329-18  Schedule III.  (a)  Thecontrolled substances listed in this section are included in schedule III.

(b)  Stimulants.  Unless listed in anotherschedule, any material, compound, mixture, or preparation which contains anyquantity of the following substances having a stimulant effect on the centralnervous system, including their salts, isomers, and salts of isomers, wheneverthe existence of these salts, isomers, and salts of isomers is possible withinthe specific chemical designation:

(1)  Those compounds, mixtures, or preparations indosage unit form containing any stimulant substance listed in schedule II, andany other drug of the quantitative composition or which is the same except thatit contains a lesser quantity of controlled substances;

(2)  Benzphetamine;

(3)  Chlorphentermine;

(4)  Clortermine;

(5)  Mazindol;

(6)  Phendimetrazine.

(c) Depressants.  Unless listed in another schedule, any material, compound,mixture, or preparation containing any quantity of the following substanceshaving a depressant effect on the central nervous system:

(1)  Any compound, mixture, or preparation containingamobarbital, secobarbital, pentobarbital, or any salt thereof and one or moreother active medicinal ingredients which are not listed in any schedule;

(2)  Any suppository dosage form containingamobarbital, secobarbital, pentobarbital, or any salt of any of these drugs andapproved by the Food and Drug Administration for marketing only as asuppository;

(3)  Any substance that contains any quantity of aderivative of barbituric acid or any salt thereof, including the substancebutalbital;

(4)  Chlorhexadol;

(5)  Embutramide (Tributame);

(6)  Ketamine, its salts, isomers, and salts ofisomers, also known as (+ or -)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;

(7)  Lysergic acid;

(8)  Lysergic acid amide;

(9)  Methyprylon;

(10)  Sulfondiethylmethane;

(11)  Sulfonethylmethane;

(12)  Sulfonmethane;

(13)  Tiletamine/Zolazepam (Telazol,2-(ethylamino)-2-(-thienyl)-cyclohexanone, flupyrazapon) or any salts thereof;and

(14)  Gammahydroxybutyric acid and its salts, isomers, and salts of isomers that arecontained in a drug product for which an application has been approved undersection 505 of the federal Food, Drug, and Cosmetic Act.

(d)  Nalorphine.

(e)  Narcotic drugs.  Unless specificallyexcepted or unless listed in another schedule, any material, compound, mixture,or preparation containing any of the following narcotic drugs, or their salts,or alkaloid, in limited quantities as set forth below:

(1)  Not more than 1.8 grams of codeine, or any of itssalts, per 100 milliliters or not more than 90 milligrams per dosage unit, withan equal or greater quantity of an isoquinoline alkaloid of opium;

(2)  Not more than 1.8 grams of codeine, or any of itssalts, per 100 milliliters or not more than 90 milligrams per dosage unit, withone or more active, nonnarcotic ingredients in recognized therapeutic amounts;

(3)  Not more than 300 milligrams of dihydrocodeinone(Hydrocodone), or any of its salts, per 100 milliliters or not more than 15milligrams per dosage unit, with a fourfold or greater quantity of anisoquinoline alkaloid of opium provided that these narcotic drugs shall bemonitored pursuant to section 329-101;

(4)  Not more than 300 milligrams of dihydrocodeinone(Hydrocodone), or any of its salts per 100 milliliters or not more than 15milligrams per dosage unit, with one or more active, nonnarcotic ingredients inrecognized therapeutic amounts provided that these narcotic drugs shall bemonitored pursuant to section 329-101;

(5)  Not more than 1.8 grams of dihydrocodeine, or anyof its salts, per 100 milliliters or not more than 90 milligrams per dosageunit, with one or more active, nonnarcotic ingredients in recognizedtherapeutic amounts;

(6)  Not more than 300 milligrams of ethylmorphine, orany of its salts, per 100 milliliters or not more than 15 milligrams per dosageunit, with one or more ingredients in recognized therapeutic amounts;

(7)  Not more than 500 milligrams of opium per 100milliliters or per 100 grams, or not more than 25 milligrams per dosage unit,with one or more active nonnarcotic ingredients in recognized therapeuticamounts;

(8)  Not more than50 milligrams of morphine or any of its salts, per 100 milliliters or per 100grams with one or more active, nonnarcotic ingredients in recognizedtherapeutic amounts; and

(9)  Buprenorphine.

(f)  The department of public safety may exceptby rule any compound, mixture, or preparation containing any stimulant ordepressant substance listed in subsections (b) and (c) from the application ofall or any part of this chapter if the compound, mixture, or preparationcontains one or more active medicinal ingredients not having a stimulant ordepressant effect on the central nervous system, and if the admixtures areincluded therein in combinations, quantity, proportion, or concentration thatvitiate the potential for abuse of the substances which have a stimulant ordepressant effect on the central nervous system.

(g)  Anyanabolic steroid.  The term "anabolic steroid" means any drug orhormonal substance chemically and pharmacologically related to testosterone(other than estrogens, progestins, and corticosteroids) that promotes musclegrowth, and includes:

(1)  Boldenone;

(2)  Clostebol (4-Chlorotestosterone);

(3)  Dehydrochlormethyltestosterone;

(4)  Dihydrotestosterone (4-dihydrotestosterone);

(5)  Drostanolone;

(6)  Ethylestrenol;

(7)  Fluoxymesterone;

(8)  Formebolone (Formyldienolone);

(9)  Mesterolone;

(10)  Methandranone;

(11)  Methandriol;

(12)  Methandrostenolone (Methandienone);

(13)  Methenolone;

(14)  Methyltestosterone;

(15)  Mibolerone;

(16)  Nandrolone;

(17)  Norethandrolone;

(18)  Oxandrolone;

(19)  Oxymesterone;

(20)  Oxymetholone;

(21)  Stanolone (Dihydrotestosterone);

(22)  Stanozolol;

(23)  Testolactone;

(24)  Testosterone;

(25)  Trenbolone;

(26)  3[beta], 17-dihydroxy-5a-androstane;

(27)  3[alpha], 17[beta]-dihydroxy-5a-androstane;

(28)  5[alpha]-androstan-3, 17-dione;

(29)  1-androstenediol (3[beta], 17[beta]-dihydroxy-5[alpha]-androst-1-ene);

(30)  1-androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene);

(31)  4-androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene);

(32)  5-androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene);

(33)  1-androstenedione ([5[alpha]]-androst-1-en-3,17-dione);

(34)  4-androstenedione (androst-4-en-3, 17-dione);

(35)  5-androstenedione (androst-5-en-3, 17-dione);

(36)  Bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);

(37)  Calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one);

(38)  [Delta]1-dihydrotestosterone (a.k.a.'1-testosterone') (17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);

(39)  Furazabol(17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan);

(40)  13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one;

(41)  4-hydroxytestosterone(4,17[beta]-dihydroxy-androst-4-en-3-one);

(42)  4-hydroxy-19-nortestosterone(4,17[beta]-dihydroxy-estr-4-en-3-one);

(43)  Mesterolone(1[alpha]methyl-17[beta]-hydroxy-[5[alpha]]-androstan-3-one);

(44)  Methandienone(17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-dien-3-one);

(45)  Methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene);

(46)  Methenolone(1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one);

(47)  17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5a-androstane;

(48)  17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane;

(49)  17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene;

(50)  17[alpha]-methyl-4-hydroxynandrolone(17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one);

(51)  Methyldienolone(17[alpha]-methyl-17[beta]-hydroxyestra-4, 9(10)-dien-3-one);

(52)  Methyltrienolone(17[alpha]-methyl-17[beta]-hydroxyestra-4, 9-11-trien-3-one);

(53)  17[alpha]-methyl-[Delta] 1-dihydrotestosterone(17b [beta]-hydroxy-17[alpha]-methyl-5[alpha]-androst-1-en-3-one) (a.k.a.'17-[alpha]-methyl-1-testosterone');

(54)  19-nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene);

(55)  19-nor-4-androstenediol (3[alpha],17[beta]-dihydroxyestr-4-ene);

(56)  19-nor-5-androstenediol (3[beta],17[beta]-dihydroxyestr-5-ene);

(57)  19-nor-5-androstenediol (3[alpha],17[beta]-dihydroxyestr-5-ene);

(58)  19-nor-4-androstenedione (estr-4-en-3, 17-dione);

(59)  19-nor-5-androstenedione (estr-5-en-3, 17-dione);

(60)  Norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one);

(61)  Norclostebol(4-chloro-17[beta]-hydroxyestr-4-en-3-one);

(62)  Normethandrolone(17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one);

(63)  Stenbolone (17[beta]-hydroxy-2-methyl-[5[alpha]]-androst-1-en-3-one);

(64)  Tetrahydrogestrinone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4, 9, 11-trien-3-one); and

(65)  Any salt,ester, or isomer of a drug or substance described or listed in this subsection,if that salt, ester, or isomer promotes muscle growth, except the term "anabolic steroid" does not include an anabolic steroid which isexpressly intended for administration through implants to cattle or othernonhuman species and which has been approved by the Secretary of Health andHuman Services for nonhuman administration.  If any person prescribes,dispenses, or distributes an anabolic steroid intended for administration tononhuman species for human use, the person shall be considered to haveprescribed, dispensed, or distributed an anabolic steroid within the meaning ofthis paragraph.

(h)  Hallucinogenic substances, unless listedin another schedule, shall include Dronabinol (synthetic), in sesame oil andencapsulated in a soft gelatin capsule in a United States Food and DrugAdministration approved drug product. [L 1972, c 10, pt of §1 and am c 114,§2(1); am L 1974, c 217, §3; am L 1975, c 26, §2; am L 1977, c 116, §2; am L1978, c 68, §4; am L 1988, c 59, §3; am L 1990, c 281, §10; am L 1991, c 159,§8; am L 1992, c 151, §1; am L 1995, c 122, §3; am L 1997, c 356, §§3, 4; am L2000, c 98, §4; am L 2001, c 203, §4; am L 2003, c 151, §4; am L 2004, c 193,§2; am L 2008, c 186, §3; am L 2009, c 117, §3]

 

Revision Note

 

  In subsection (g)(59), a closing parenthesis was added afterthe word "dione".